The Brain Metabolic Signature in Superagers Using In Vivo ¹H-MRS: A Pilot Study

References

1. 1.↵
   2. de Godoy LL,
   3. Alves CA,
   4. Saavedra JS, et al

   . Understanding brain resilience in superagers: a systematic review. Neuroradiology 2021;63:663–83 doi:10.1007/s00234-020-02562-1 pmid:32995945

   CrossRefPubMed
2. 2.↵
   2. Harrison TM,
   3. Weintraub S,
   4. Mesulam MM, et al

   . Superior memory and higher cortical volumes in unusually successful cognitive aging. J Int Neuropsychol Soc 2012;18:1081–85 doi:10.1017/S1355617712000847 pmid:23158231

   CrossRefPubMed
3. 3.↵
   2. Gefen T,
   3. Peterson M,
   4. Papastefan ST, et al

   . Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity. J Neurosci 2015;35:1781–91 doi:10.1523/JNEUROSCI.2998-14.2015 pmid:25632151

   Abstract/FREE Full Text
4. 4.↵
   2. Wang X,
   3. Ren P,
   4. Baran TM, et al

   . Alzheimer's Disease Neuroimaging Initiative. Longitudinal functional brain mapping in supernormals. Cereb Cortex 2019;29:242–52 doi:10.1093/cercor/bhx322 pmid:29186360

   CrossRefPubMed
5. 5.↵
   2. Zhang J,
   3. Andreano JM,
   4. Dickerson BC, et al

   . Stronger functional connectivity in the default mode and salience networks is associated with youthful memory in superaging. Cereb Cortex 2020;30:72–84 doi:10.1093/cercor/bhz071 pmid:31058917

   CrossRefPubMed
6. 6.↵
   2. Cleeland C,
   3. Pipingas A,
   4. Scholey A, et al

   . Neurochemical changes in the aging brain: a systematic review. Neurosci Biobehav Rev 2019;98:306–19 doi:10.1016/j.neubiorev.2019.01.003 pmid:30625337

   CrossRefPubMed
7. 7.↵
   2. Jung RE,
   3. Gasparovic C,
   4. Chavez RS, et al

   . Imaging intelligence with proton magnetic resonance spectroscopy. Intelligence 2009;37:192–98 doi:10.1016/j.intell.2008.10.009 pmid:19936275

   CrossRefPubMed
8. 8.↵
   2. Jung RE,
   3. Yeo RA,
   4. Chiulli SJ, et al

   . Myths of neuropsychology: intelligence, neurometabolism, and cognitive ability. Clin Neuropsychol 2000;14:535–45 doi:10.1076/clin.14.4.535.7198 pmid:11262722

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Jung RE,
   3. Brooks WM,
   4. Yeo RA, et al

   . Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain. Proc Bio Sci 1999;266:1375–79 doi:10.1098/rspb.1999.0790 pmid:10445292

   CrossRefPubMed
10. 10.↵
    2. Jung RE,
    3. Yeo RA,
    4. Love TM, et al

    . Biochemical markers of mood: a proton magnetic resonance spectroscopy study of normal human brain. Biol Psychiatry 2002;51:224–29 doi:10.1016/S0006-3223(01)01224-0 pmid:11839365

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Jung RE,
    3. Gasparovic C,
    4. Chavez RS, et al

    . Biochemical support for the “Threshold” theory of creativity: a magnetic resonance spectroscopy study. J Neurosci 2009;29:5319–25 doi:10.1523/JNEUROSCI.0588-09.2009 pmid:19386928

    Abstract/FREE Full Text
12. 12.↵
    2. Ryman SG,
    3. Gasparovic C,
    4. Bedrick EJ, et al

    . Brain biochemistry and personality: a magnetic resonance spectroscopy study. PLoS One 2011;6:e26758 doi:10.1371/journal.pone.0026758 pmid:22073190

    CrossRefPubMed
13. 13.↵
    2. Lee MR,
    3. Denic A,
    4. Hinton DJ, et al

    . Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. Bioanalysis 2012;4:1787–804 doi:10.4155/bio.12.129 pmid:22877223

    CrossRefPubMed
14. 14.↵
    2. Harris JL,
    3. Yeh HW,
    4. Swerdlow RH, et al

    . High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiol Aging 2014;35:1686–94 doi:10.1016/j.neurobiolaging.2014.01.018 pmid:24559659

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Schmitt F,
    3. Grosu D,
    4. Mohr C, et al

    . 3 Tesla MRI: successful results with higher field strengths. Radiologe 2004;44:31–47 doi:10.1007/s00117-003-1000-x pmid:14997868

    CrossRefPubMed
16. 16.↵
    2. Jansen JF,
    3. Backes WH,
    4. Nicolay K, et al

    . 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240:318–32 doi:10.1148/radiol.2402050314 pmid:16864664

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Chiu PW,
    3. Mak HK,
    4. Yau KK, et al

    . Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3T. Age (Dordr) 2014;36:251–64 doi:10.1007/s11357-013-9545-8 pmid:23709317

    CrossRefPubMed
18. 18.↵
    2. Oz G,
    3. Alger JR,
    4. Barker PB, et al

    . MRS Consensus Group. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014;270:658–79 doi:10.1148/radiol.13130531 pmid:24568703

    CrossRefPubMed
19. 19.↵
    2. Folstein MF,
    3. Folstein SE,
    4. McHugh PR

    . Mini-Mental State: a practical guide for grading the mental state of patients for the clinician. J Psych Res 1975;12:189–98 doi:10.1016/0022-3956(75)90026-6 pmid:1202204

    CrossRefPubMed
20. 20.↵
    2. Brucki S,
    3. Nitrini R,
    4. Caramelli P, et al

    . Suggestions for utilization of the mini-mental state examination in Brazil [in Portuguese]. Arq Neuropsiquiatr 2003;61:777–81 doi:10.1590/S0004-282X2003000500014 pmid:14595482

    CrossRefPubMed
21. 21.↵
    2. Pfeffer RI,
    3. Kurosaki TT,
    4. Harrah CH Jr., et al

    . Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323–29 doi:10.1093/geronj/37.3.323 pmid:7069156

    CrossRefPubMedWeb of Science
22. 22.↵
    2. McKhann GM,
    3. Knopman DS,
    4. Chertkow H, et al

    . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263–69 doi:10.1016/j.jalz.2011.03.005 pmid:21514250

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Albert MS,
    3. DeKosky ST,
    4. Dickson D, et al

    . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–79 doi:10.1016/j.jalz.2011.03.008 pmid:21514249

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Nitrini R,
    3. Caramelli P,
    4. Porto CS, et al

    . Brief cognitive battery in the diagnosis of mild Alzheimer's disease in subjects with medium and high levels of education. Dement Neuropsychol 2007;1:32–36 doi:10.1590/S1980-57642008DN10100006 pmid:29213365

    CrossRefPubMed
25. 25.↵
    2. Rogalski EJ,
    3. Gefen T,
    4. Shi J, et al

    . Youthful memory capacity in old brains: anatomic and genetic clues from the Northwestern SuperAging Project. J Cogn Neurosci 2013;25:29–36 doi:10.1162/jocn_a_00300 pmid:23198888

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Heaton RK,
    3. Miller SW,
    4. Taylor MJ, et al

    . Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms For African American and Caucasian adults. 2004. http://www4.parinc.com/Products/Product.aspx?ProductID=RCNAAC. Accessed September 10, 2020
27. 27.↵
    2. Shirk SD,
    3. Mitchell MB,
    4. Shaughnessy LW, et al

    . A web-based normative calculator for the Uniform Data Set (UDS) neuropsychological test battery. Alzheimers Res Ther 2011;3:32 doi:10.1186/alzrt94 pmid:22078663

    CrossRefPubMed
28. 28.↵
    2. Provencher SW

    . Estimation of metabolite concentrations from localizedin vivo proton NMR spectra. Magn Reson Med 1993;30:672–79 doi:10.1002/mrm.1910300604 pmid:8139448

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Seeger U,
    3. Klose U,
    4. Mader I, et al

    . Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn Reson Med 2003;49:19–28 doi:10.1002/mrm.10332 pmid:12509816

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Kreis R,
    3. Ernst T,
    4. Ross BD

    . Absolute quantitation of water and metabolites in the human brain, II: metabolite concentrations. J Magn Reson B 1993;102:9–19 doi:10.1006/jmrb.1993.1056

    CrossRefWeb of Science
31. 31.↵
    2. Ernst T,
    3. Kreis R,
    4. Ross BD

    . Absolute quantitation of water and metabolites in the human brain, I: compartments and water. J Magn Reson B 1993;102:1–8 doi:10.1006/jmrb.1993.1055

    CrossRefWeb of Science
32. 32.↵
    2. Edden RA,
    3. Puts NA,
    4. Harris AD, et al

    . Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging 2014;40:1445–52 doi:10.1002/jmri.24478 pmid:25548816

    CrossRefPubMed
33. 33.↵
    2. Friston KJ,
    3. Holmes AP,
    4. Worsley KJ, et al

    . Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1994;2:189–210 doi:10.1002/hbm.460020402

    CrossRef
34. 34.↵
    2. Pedrosa de Barros N,
    3. Slotboom J

    . Quality management in in vivo proton MRS. Anal Biochem 2017;529:98–116 doi:10.1016/j.ab.2017.01.017 pmid:28115170

    CrossRefPubMed
35. 35.↵
    2. Simpson R,
    3. Devenyi GA,
    4. Jezzard P, et al

    . Advanced processing and simulation of MRS data using the FID appliance (FID-A): an open source, MATLAB-based toolkit. Magn Reson Med 2017;77:23–33 doi:10.1002/mrm.26091 pmid:26715192

    CrossRefPubMed
36. 36.↵
    2. Charlton RA,
    3. McIntyre DJO,
    4. Howe FA, et al

    . The relationship between white matter brain metabolites and cognition in normal aging: the GENIE study. Brain Res 2007;1164:108–16 doi:10.1016/j.brainres.2007.06.027 pmid:17632090

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Driscoll I,
    3. Hamilton DA,
    4. Petropoulos H, et al

    . The aging hippocampus: cognitive, biochemical and structural findings. Cereb Cortex 2003;13:1344–51 doi:10.1093/cercor/bhg081 pmid:14615299

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Ross AJ,
    3. Sachdev PS,
    4. Wen W, et al

    . Cognitive correlates of 1H MRS measures in the healthy elderly brain. Brain Res Bull 2005;66:9–16 doi:10.1016/j.brainresbull.2005.01.015 pmid:15925139

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Kochunov P,
    3. Coyle T,
    4. Lancaster J, et al

    . Processing speed is correlated with cerebral health markers in the frontal lobes as quantified by neuroimaging. Neuroimage 2010;49:1190–99 doi:10.1016/j.neuroimage.2009.09.052 pmid:19796691

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Erickson KI,
    3. Weinstein AM,
    4. Sutton BP, et al

    . Beyond vascularization: aerobic fitness is associated with N-acetylaspartate and working memory. Brain Behav 2012;2:32–41 doi:10.1002/brb3.30 pmid:22574272

    CrossRefPubMed
41. 41.↵
    2. Gomar JJ,
    3. Gordon ML,
    4. Dickinson D, et al

    . APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain. Biol Psychiatry 2014;75:686–92 doi:10.1016/j.biopsych.2013.05.022 pmid:23831342

    CrossRefPubMed
42. 42.↵
    2. Rogalski EJ

    . Don't forget: age is a relevant variable in defining SuperAgers. Alzheimers Dement (Amst) 2019;11:560–61 doi:10.1016/j.dadm.2019.05.008 pmid:31909169

    CrossRefPubMed
43. 43.↵
    2. Nyberg L,
    3. Lövdén M,
    4. Riklund K, et al

    . Memory aging and brain maintenance. Trends Cogn Sci 2012;16:292–305 doi:10.1016/j.tics.2012.04.005 pmid:22542563

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Borelli WV,
    3. Carmona KC,
    4. Studart-Neto A, et al

    . Operationalized definition of older adults with high cognitive performance. Dement Neuropsychol 2018;12:221–27 doi:10.1590/1980-57642018dn12-030001 pmid:30425784

    CrossRefPubMed
45. 45.↵
    2. Minoshima S,
    3. Giordani B,
    4. Berent S, et al

    . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85–94 doi:10.1002/ana.410420114 pmid:9225689

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Lehmann M,
    3. Rohrer JD,
    4. Clarkson MJ, et al

    . Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. J Alzheimers Dis 2010;20:587–98 doi:10.3233/JAD-2010-1401 pmid:20182057

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Park EJ,
    3. Lyra KP,
    4. Lee HW, et al

    . Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease. Dement Neuropsychol 2010;4:109–13 doi:10.1590/S1980-57642010DN40200006 pmid:29213672

    CrossRefPubMed
48. 48.↵
    2. Scavuzzo CJ,
    3. Moulton CJ,
    4. Larsen RJ

    . The use of magnetic resonance spectroscopy for assessing the effect of diet on cognition. Nutr Neurosci 2018;21:1–15 doi:10.1080/1028415X.2016.1218191 pmid:27571302

    CrossRefPubMed
49. 49.↵
    2. Chakraborty G,
    3. Mekala P,
    4. Yahya D, et al

    . Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 2001;78:736–45 doi:10.1046/j.1471-4159.2001.00456.x pmid:11520894

    CrossRefPubMedWeb of Science
50. 50.↵
    2. White TL,
    3. Gonsalves MA,
    4. Cohen RA, et al

    . The neurobiology of wellness: 1H-MRS correlates of agency, flexibility and neuroaffective reserves in healthy young adults. Neuroimage 2021;225:117509 doi:10.1016/j.neuroimage.2020.117509 pmid:33127477

    CrossRefPubMed
51. 51.↵
    2. Jewsbury PA,
    3. Bowden SC,
    4. Duff K

    . The Cattell–Horn–Carroll Model of cognition for clinical assessment. J Psychoeduc Assess 2017;35:547–67 doi:10.1177/0734282916651360

    CrossRef
52. 52.↵
    2. Hädel S,
    3. Wirth C,
    4. Rapp M, et al

    . Effects of age and sex on the concentrations of glutamate and glutamine in the human brain. J Magn Reson Imaging 2013;38:1480–87 doi:10.1002/jmri.24123 pmid:23564615

    CrossRefPubMed
53. 53.↵
    2. Marjańska M,
    3. Riley McCarten J,
    4. Hodges J, et al

    . Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using 1H magnetic resonance spectroscopy at 7 T. Neuroscience 2017;354:168–77 doi:10.1016/j.neuroscience.2017.04.035 pmid:28476320

    CrossRefPubMed
54. 54.↵
    2. Sailasuta N,
    3. Ernst T,
    4. Chang L

    . Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magnetic Resonance Imaging 2008;26:667–75 doi:10.1016/j.mri.2007.06.007 pmid:17692491

    CrossRefPubMedWeb of Science
55. 55.↵
    2. Yang ZY,
    3. Yue Q,
    4. Xing HY, et al

    . A quantitative analysis of (1)H-MR spectroscopy at 3.0 T of three brain regions from childhood to middle age. Br J Radiol 2015;88:20140693 doi:10.1259/bjr.20140693 pmid:26081448

    CrossRefPubMed
56. 56.↵
    2. Zahr NM,
    3. Mayer D,
    4. Rohlfing T, et al

    . In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol Aging 2013;34:1265–76 doi:10.1016/j.neurobiolaging.2012.09.014 pmid:23116877

    CrossRefPubMed
57. 57.↵
    2. Eylers VV,
    3. Maudsley AA,
    4. Bronzlik P, et al

    . Detection of normal aging effects on human brain metabolite concentrations and microstructure with whole-brain MR spectroscopic imaging and quantitative MR imaging. AJNR Am J Neuroradiol 2016;37:447–54 doi:10.3174/ajnr.A4557 pmid:26564440

    Abstract/FREE Full Text
58. 58.↵
    2. Ding, XQ,
    3. Maudsley, AA,
    4. Sabati, M, et al

    . Physiological neuronal decline in healthy aging human brain: an in vivo study with MRI and short echo-time whole-brain 1H MR spectroscopic imaging. Neuroimage 2016;137:45–51 doi:10.1016/j.neuroimage.2016.05.014 pmid:27164326

    CrossRefPubMed
59. 59.↵
    2. Drachman DA

    . Aging of the brain, entropy, and Alzheimer disease. Neurology 2006;67:1340–52 doi:10.1212/01.wnl.0000240127.89601.83 pmid:17060558

    Abstract/FREE Full Text
60. 60.↵
    2. Peters A,
    3. Morrison JH,
    4. Rosene DL, et al

    . Feature article: are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 1998;8:295–300 doi:10.1093/cercor/8.4.295 pmid:9651126

    CrossRefPubMedWeb of Science
61. 61.↵
    2. Woods DL,
    3. Wyma JM,
    4. Herron TJ, et al

    . The effects of aging, malingering, and traumatic brain injury on computerized trail-making test performance. PLoS One 2015;10:e0124345 doi:10.1371/journal.pone.0124345 pmid:26060999

    CrossRefPubMed
62. 62.↵
    2. Graff-Radford J,
    3. Kantarci K

    . Magnetic resonance spectroscopy in Alzheimer's disease. Neuropsychiatr Dis Treat 2013;9:687–96 doi:10.2147/NDT.S35440 pmid:23696705

    CrossRefPubMed
63. 63.↵
    2. Coutinho A,
    3. Porto FH,
    4. Zampieri PF, et al

    . Analysis of the posterior cingulate cortex with [18 F] FDG-PET and NAA/mI in mild cognitive impairment and Alzheimer's disease: correlations and differences between the two methods. Dement Neuropsychol 2015;9:385–93 doi:10.1590/1980-57642015DN94000385 pmid:29213988

    CrossRefPubMed
64. 64.↵
    2. Nedelska Z,
    3. Przybelski SA,
    4. Lesnick TG, et al

    . 1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults. Neurology 2017;89:1391–99 doi:10.1212/WNL.0000000000004421 pmid:28842444

    Abstract/FREE Full Text
65. 65.↵
    2. Voevodskaya O,
    3. Poulakis K,
    4. Sundgren P, et al

    . Swedish BioFINDER Study Group. Brain myoinositol as a potential marker of amyloid-related pathology: a longitudinal study. Neurology 2019;92:e395–405 doi:10.1212/WNL.0000000000006852

    Abstract/FREE Full Text
66. 66.↵
    2. Sanabria ER,
    3. Wozniak KM,
    4. Slusher BS, et al

    . GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism. J Neurophysiol 2004;91:182–93 doi:10.1152/jn.00465.2003 pmid:12917384

    CrossRefPubMedWeb of Science
67. 67.↵
    2. Zhong C,
    3. Zhao X,
    4. Van KC, et al

    . NAAG, peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat. J Neurochem 2006;97:1015–25 doi:10.1111/j.1471-4159.2006.03786.x pmid:16606367

    CrossRefPubMed
68. 68.↵
    2. Berent-Spillson A,
    3. Robinson AM,
    4. Golovoy D, et al

    . Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J Neurochem 2004;89:90–99 doi:10.1111/j.1471-4159.2003.02321.x pmid:15030392

    CrossRefPubMedWeb of Science
69. 69.↵
    2. Berent-Spillson A,
    3. Russell JW

    . Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. J Neurochem 2007;101:342–54 doi:10.1111/j.1471-4159.2006.04373.x pmid:17402968

    CrossRefPubMedWeb of Science
70. 70.↵
    2. Kuehn BM

    . In Alzheimer research, glucose metabolism moves to center stage. JAMA 2020;323:297–99 doi:10.1001/jama.2019.20939 pmid:31913419

    CrossRefPubMed
71. 71.↵
    2. Gruber S,
    3. Pinker K,
    4. Riederer F, et al

    . Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol 2008;68:320–27 doi:10.1016/j.ejrad.2007.08.038 pmid:17964104

    CrossRefPubMedWeb of Science
72. 72.↵
    2. David JP,
    3. Ghozali F,
    4. Fallet-Bianco C, et al

    . Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci Lett 1997;235:53–56 doi:10.1016/s0304-3940(97)00708-8 pmid:9389594

    CrossRefPubMedWeb of Science
73. 73.↵
    2. Sandhir R,
    3. Onyszchuk G,
    4. Berman NE

    . Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 2008;213:372–80 doi:10.1016/j.expneurol.2008.06.013 pmid:18692046

    CrossRefPubMedWeb of Science
74. 74.↵
    2. Duarte JM,
    3. Do KQ,
    4. Gruetter R

    . Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy. Neurobiol Aging 2014;35:1660–68 doi:10.1016/j.neurobiolaging.2014.01.135 pmid:24560998

    CrossRefPubMed
75. 75.↵
    2. Novotny EJ Jr.,
    3. Fulbright RK,
    4. Pearl PL, et al

    . Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol 2003;54(Suppl 6):S25–31 doi:10.1002/ana.10697 pmid:12891651

    CrossRefPubMed
76. 76.↵
    2. Hoyer C,
    3. Gass N,
    4. Weber-Fahr W, et al

    . Advantages and challenges of small animal magnetic resonance imaging as a translational tool. Neuropsychobiology 2014;69:187–201 doi:10.1159/000360859 pmid:24863537

    CrossRefPubMed
77. 77.↵
    2. Ramadan S,
    3. Lin A,
    4. Stanwell P

    . Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed 2013;26:1630–46 doi:10.1002/nbm.3045 pmid:24123328

    CrossRefPubMedWeb of Science
78. 78.↵
    2. Zeydan B,
    3. Deelchand DK,
    4. Tosakulwong N, et al

    . Decreased glutamate levels in patients with amnestic mild cognitive impairment: an sLASER proton MR spectroscopy and PiB-PET study. J Neuroimaging 2017;27:630–36 doi:10.1111/jon.12454 pmid:28661060

    CrossRefPubMed
79. 79.↵
    2. Wong D,
    3. Atiya S,
    4. Fogarty J, et al

    . Reduced hippocampal glutamate and posterior cingulate N-acetyl aspartate in mild cognitive impairment and Alzheimer's disease is associated with episodic memory performance and white matter integrity in the cingulum: a pilot study. J Alzheimers Dis 2020;73:1385–405 doi:10.3233/JAD-190773 pmid:31958093

    CrossRefPubMed
80. 80.↵
    2. Suri S,
    3. Emir U,
    4. Stagg CJ, et al

    . Effect of age and the APOE gene on metabolite concentrations in the posterior cingulate cortex. Neuroimage 2017;152:509–16 doi:10.1016/j.neuroimage.2017.03.031 pmid:28323160

    CrossRefPubMed
81. 81.↵
    2. Reyngoudt H,
    3. Claeys T,
    4. Vlerick L, et al

    . Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study. Eur J Radiol 2012;81:e223–31 doi:10.1016/j.ejrad.2011.01.106

    CrossRefPubMed
82. 82.↵
    2. Kim BR,
    3. Kwon H,
    4. Chun MY, et al

    . White matter integrity is associated with the amount of physical activity in older adults with super-aging. Front Aging Neurosci 2020;12:549983 doi:10.3389/fnagi.2020.549983] pmid:33192451

    CrossRefPubMed
83. 83.↵
    2. Huentelman MJ,
    3. Piras IS,
    4. Siniard AL, et al

    . Associations of MAP2K3 gene variants with superior memory in SuperAgers. Front Aging Neurosci 2018;10:155 doi:10.3389/fnagi.2018.00155 pmid:29896098

    CrossRefPubMed
84. 84.↵
    2. Kreis R,
    3. Slotboom J,
    4. Hofmann L, et al

    . Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med 2005;54:761–68 doi:10.1002/mrm.20673 pmid:16161114

    CrossRefPubMed